Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: results from the EPATH randomized, placebo-controlled trial

Tomaschitz, Andreas; Verheyen, Nicolas; Meinitzer, Andreas; Pieske, Burkert; Belyavskiy, Evgeny; Brussee, Helmut; Haas, Josef; Maerz, Winfried; Pieske-Kraigher, Elisabeth; Verheyen, Sarah; Ofner-Ziegenfuss, Lisa; Hartaigh, Briain O.; Schwetz, Verena; Aberer, Felix; Grubler, Martin; Lang, Florian; Alesutan, Ioana; Voelkl, Jakob; Gaksch, Martin; Horina, Joerg H.; Dimai, Hans-Peter; Rus-Machan, Jutta; Stiegler, Claudia; Ritz, Eberhard; Fahrleitner-Pammer, Astrid; Pilz, Stefan

Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: results from the EPATH randomized, placebo-controlled trial

Author:

Tomaschitz, Andreas; Verheyen, Nicolas; Meinitzer, Andreas; Pieske, Burkert; Belyavskiy, Evgeny; Brussee, Helmut; Haas, Josef; Maerz, Winfried; Pieske-Kraigher, Elisabeth; Verheyen, Sarah; Ofner-Ziegenfuss, Lisa; Hartaigh, Briain O.; Schwetz, Verena; Aberer, Felix; Grubler, Martin; Lang, Florian; Alesutan, Ioana; Voelkl, Jakob; Gaksch, Martin; Horina, Joerg H.; Dimai, Hans-Peter; Rus-Machan, Jutta; Stiegler, Claudia; Ritz, Eberhard; Fahrleitner-Pammer, Astrid; Pilz, Stefan

Tübinger Autor(en):

Lang, Florian
Alesutan, Ioana Simona
Völkl, Jakob Georg Jonathan

Published in:

Journal of Hypertension (2016), Bd. 34, H. 7, S. 1347-1356

Verlagsangabe:

Lippincott Williams & Wilkins

Language:

English

Full text:

http://dx.doi.org/10.1097/HJH.0000000000000927

ISSN:

1473-5598